Search for: "Art Speciality Co., Inc." Results 181 - 200 of 488
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 May 2007, 6:11 am
Bridge Medical, Inc. (05/18/2007): appeal of dismissal of infringement suit after district court determined that the patent in suit was unenforceable due to inequitable conduct (affirmed); discussion of patent related to a patient identification system using bar codes on the patient and his or her medications (U.S. [read post]
7 Jan 2011, 3:11 am by Kelly
Belkin International, Inc., et. al (Docket Report) District Court C D California: Diligence asserting inequitable conduct measured from date prior art was known to be relevant, not date prior art was known to exist: Aten International Co. [read post]
24 Dec 2007, 7:01 am
Croix, VI 00840 Phone: (340) 772-1200 TTY: (340) 772-4641 Fax: (340) 772-0609 E-mail: info@viadvocacy.org Web: http://www.viadvocacy.org Client Assistance Program Contact Protection & Advocacy Agency OTHER DISABILITY ORGANIZATIONS Very Special Arts Virgin Islands P.O. [read post]
15 Feb 2010, 4:04 am
Montgomery Ward & Co (Patently-O) (Patently-O) (GRAY On Claims) (Inventive Step) (Patently-O) District Court S D Iowa: Intent to deceive inferred when plaintiff adds element to patent claims to overcome rejection but fails to disclose prior art containing that element: Sabasta et al v Buckaroos, Inc (Docket Report) District Court E D New York: Failure to disclose specific combination of prior art precludes invalidity argument based on such combination: Metso… [read post]
17 May 2015, 4:00 am by Administrator
Securities: Standard for Class Actions in QuébecTheratechnologies inc. v. 121851 Canada inc., 2015 SCC 18 (35550) The “reasonable possibility” of success required under s. 225.4 sets out a different and higher standard than the general threshold for the authorization of a class action under art. 1003 of the C.C.P. [read post]
11 Sep 2019, 1:00 pm by Oswin Ridderbusch
The specific DP IV inhibitor sitagliptin as such, however, is not identified in Royalty Pharma’s basic patent as it was developed only after the filing date of the patent (and gave rise to a distinct patent filed by Merck & Co., Inc.). [read post]
1 Feb 2012, 11:15 pm
" Hewlett-Packard Co. v. [read post]